Sign in
Author
|
Conference
|
Journal
|
Organization
|
Year
|
DOI
Look for results that meet for the following criteria:
since
equal to
before
between
and
Search in all fields of study
Limit my searches in the following fields of study
Agriculture Science
Arts & Humanities
Biology
Chemistry
Computer Science
Economics & Business
Engineering
Environmental Sciences
Geosciences
Material Science
Mathematics
Medicine
Physics
Social Science
Multidisciplinary
Co-authors
(16)
David G. Michelson
2
Arnold R. Gammaitoni
2
Tony W. Ho
2
Bradley S. Galer
2
James A. Bolognese
2
Journals
(5)
J CLIN PSYCHOPHARMACOL
2
J PAIN
1
Pain
1
BRIT J PSYCHIAT
1
J PERS DISORD
1
Keywords
(9)
Embed
Subscribe
Academic
Authors
PAUL J. MARKOVITZ
PAUL J. MARKOVITZ,Psychiatry & Psychology,Pharmacology,Neuroscience
Edit
PAUL J. MARKOVITZ
Publications:
6
|
Citations:
44
Fields:
Psychiatry & Psychology
,
Pharmacology
,
Neuroscience
View FAQ about top research areas and Fields of study
Collaborated with
16 co-authors
from 1991 to 2011
|
Cited by
134 authors
Cumulative
Annual
Sort by:
Publications
(6)
BibTeX
|
RIS
|
RefWorks
Download
Impact of responder definition on the enriched enrollment randomized withdrawal trial design for establishing proof of concept in neuropathic pain
(
Citations: 1
)
David J. Hewitt
,
Tony W. Ho
,
Bradley Galer
,
Miroslav Backonja
,
Paul Markovitz
,
Arnold Gammaitoni
,
David Michelson
,
James Bolognese
,
Achilles Alon
,
Elizabeth Rosenberg
,
Gary Herman
,
Hao Wang
Journal:
Pain
, vol. 152, no. 3, pp. 514-521, 2011
The potential of the Enriched Enrollment Randomized Withdrawal (EERW) paradigm for proof of concept studies of novel agents for the treatment of neuropathic pain (NP)
D. Hewitt
,
J. Bolognese
,
A. Gammaitoni
,
D. Michelson
,
A. Alon
,
T. Ho
,
B. Galer
,
M. Backonja
,
H. Wang
,
P. Markovitz
Journal:
Journal of Pain - J PAIN
, vol. 10, no. 4, pp. S40-S40, 2009
Recent Trends in the Pharmacotherapy of Personality Disorders
(
Citations: 13
)
Paul J. Markovitz
Journal:
Journal of Personality Disorders - J PERS DISORD
, vol. 18, no. 1, pp. 90-101, 2004
Drug treatment of personality disorders
(
Citations: 2
)
P. J. Markovitz
,
S. C. Schulz
Journal:
British Journal of Psychiatry - BRIT J PSYCHIAT
, vol. 162, no. 1, pp. 122-122, 1993
Fluoxetine Responsivity Mediated by Serum Levels, Not Dose
EILEEN M. SCHWARTZ
,
PAUL J. MARKOVITZ
Journal:
Journal of Clinical Psychopharmacology - J CLIN PSYCHOPHARMACOL
, vol. 13, no. 5, 1993
Sort by:
Citations
(44 times by 44 publications)
Designing Phase 2 Trials Based on Program-Level Considerations: A Case Study for Neuropathic Pain
Nitin Patel
,
James Bolognese
,
Christy Chuang-Stein
,
David Hewitt
,
Arnold Gammaitoni
,
Jose Pinheiro
Journal:
Drug Information Journal - DRUG INF J
, vol. 46, no. 4, pp. 439-454, 2012
An analysis of the high psychotropic off-label use in psychiatric disorders
(
Citations: 1
)
Kavi K. Devulapalli
,
Henry A. Nasrallah
Journal:
Asian Journal of Psychiatry
, vol. 2, no. 1, pp. 29-36, 2009
Clozapine Monotherapy for 66 Months in Treatment Resistant Bipolar Disorder: A Case Report
Maneesh Gupta
Journal:
Journal of Clinical Psychopharmacology - J CLIN PSYCHOPHARMACOL
, vol. 29, no. 5, pp. 501-503, 2009
An orbitofrontostriatopallidal pathway for morality: Evidence from postlesion antisocial and obsessive-compulsive disorder
(
Citations: 3
)
Claude M. J. Braun
,
Cathy Léveillé
,
Anik Guimond
Journal:
Cognitive Neuropsychiatry
, vol. 13, no. 4, pp. 296-337, 2008
Aripiprazole monotherapy in patients with rapid-cycling bipolar I disorder: an analysis from a long-term, double-blind, placebo-controlled study
(
Citations: 6
)
D. J. Muzina
,
C. Momah
,
J. M. Eudicone
,
A. Pikalov
,
R. D. McQuade
,
R. N. Marcus
,
R. Sanchez
,
B. X. Carlson
Journal:
International Journal of Clinical Practice - INT J CLIN PRACT
, vol. 62, no. 5, pp. 679-687, 2008
Comments